Endocrinology (all articles)
Guideline Synopsis: Primary Prevention of Cardiovascular Disease
7 Oct, 2019 | 05:54h | UTCPrimary Prevention of Cardiovascular Disease – JAMA (free for a limited period)
Original Guideline: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (free guideline and resources)
Related Summaries: The ABCs of Primary Cardiovascular Prevention: 2019 Update – American College of Cardiology (free) AND Key Points From the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease – American College of Cardiology (free)
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
7 Oct, 2019 | 01:04h | UTCHyperinsulinemia: An Early Indicator of Metabolic Dysfunction – Journal of the Endocrine Society (free)
Review: Medical Treatment of Primary Aldosteronism
4 Oct, 2019 | 08:04h | UTCMedical treatment of primary aldosteronism – European Journal of Endocrinology (free)
Review: Ultrasound Imaging Classifications of Thyroid Nodules for Malignancy Risk Stratification and Clinical Management
4 Oct, 2019 | 07:18h | UTC
Review: MRI of Adrenal Gland
4 Oct, 2019 | 07:20h | UTCMagnetic resonance imaging of adrenal gland: state of the art – Gland Surgery (free)
Case Report: Perioperative Management in a Patient with Panhypopituitarism – Evidence Based Approach
4 Oct, 2019 | 07:15h | UTC
Updated Meta-Analysis of Randomized Trials Suggests Marine Omega‐3 Supplementation Reduces Cardiovascular Disease
3 Oct, 2019 | 07:25h | UTCCommentary: Omega-3 fish oil supplements linked with lower cardiovascular disease risk – Harvard T.H. Chan School of Public Health (free) AND Latest fish oil analysis suggests omega-3s promote heart health – Cardiovascular Business (free)
Consensus Statement: Unmet Therapeutic, Educational and Scientific Needs in Parathyroid Disorders
2 Oct, 2019 | 22:25h | UTC
Meat’s Bad for You! No, It’s Not! How Experts See Different Things in the Data
2 Oct, 2019 | 02:02h | UTCMeat’s Bad for You! No, It’s Not! How Experts See Different Things in the Data – The New York Times (10 articles per month are free)
See also: Is eating beef healthy? The new fight raging in nutrition science, explained. – Vox (free)
Original Article: Guideline: It Is NOT Necessary to Reduce Red and Processed Meat Consumption (free guideline and commentaries)
Guideline: It Is NOT Necessary to Reduce Red and Processed Meat Consumption
1 Oct, 2019 | 01:01h | UTCEditorial: Meat Consumption and Health: Food for Thought (free)
Related Annals of Internal Medicine Systematic Reviews: Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes (free) AND Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes (free) AND Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence (free) AND Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes (free) AND Health-Related Values and Preferences Regarding Meat Consumption (free)
Commentaries: Eat Less Red Meat, Scientists Said. Now Some Believe That Was Bad Advice. – The New York Times (10 articles per month are free) AND Red and processed meat are OK to eat, controversial new guidelines claim. Don’t believe it, leading experts say – CNN (free) AND Expert reaction to new papers looking at red and processed meat consumption and health – Science Media Centre (free)
Observational Study Suggests an Increase in Mental Health Service Use After Bariatric Surgery
1 Oct, 2019 | 00:50h | UTCIncidence and Determinants of Mental Health Service Use After Bariatric Surgery – JAMA Psychiatry (free for a limited period)
Commentaries: Patients more likely to seek psychiatric help after weight-loss surgery – Reuters (free) AND Mental health service use up after bariatric surgery – MedicalXpress (free)
[Abstract Only] Study: Certain Racial/Ethnic Groups More Likely to Have Diabetes and Prediabetes at Lower Weights
1 Oct, 2019 | 00:46h | UTCRacial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S. – Diabetes Care (link to abstract – $ for full-text)
Commentaries: Members of minority groups more likely to have diabetes at lower weights – News Medical (free) AND Rates of Diabetes Higher at Lower BMIs Among Minorities – Endocrinology Advisor (free) AND Minorities More Likely Than Whites to Have Diabetes at Normal BMI – Medscape (free registration required)
Systematic Review: Management of Diabetic Foot Based on Clinical Practice Guidelines
1 Oct, 2019 | 00:49h | UTCRelated: Diabetic foot problems: prevention and management – National Institute for Health and Care Excellence (free) AND The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine (free) AND Diabetic foot – The BMJ (free) AND Diagnosis and Management of Diabetic Foot Complications – American Diabetes Association (free)
Population-Based Observational Study Suggests Statins at Higher Doses May Increase the Incidence of Osteoporosis
1 Oct, 2019 | 00:45h | UTCCommentary: Statins could increase or decrease osteoporosis risk — the dosage makes the difference – Complexity Science Hub Vienna (free)
Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting
1 Oct, 2019 | 00:41h | UTC
Cohort Studies: Increasing Nut Consumption Associated with Less Weight Gain and Lower Risk of Obesity
26 Sep, 2019 | 08:31h | UTCCommentaries: Boosting daily nut consumption linked to less weight gain and lower obesity risk – The BMJ (free) AND Higher daily nut consumption linked to lower weight gain – OnMedica (free) AND Eating more nuts may help prevent weight gain – Medical News Today (free)
ASCO Guideline: Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease
22 Sep, 2019 | 23:02h | UTC
[Abstract Only] Randomized Trial: SGLT2 Inhibitor Improves Outcomes in Patients with Heart Failure Even in the Absence of Diabetes
20 Sep, 2019 | 08:27h | UTCDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine (link to abstract – $ for full-text)
Related 2019 ESC Congress News Release, Before Publication: Randomized Trial: SGLT2 inhibitors Seems Beneficial for Heart Failure Even in Nondiabetics (free commentaries)
Commentaries: SGLT2 Inhibitor Dapagliflozin Lowers Risk for Worsening Heart Failure – NEJM Journal Watch (free) AND New research shows dapagliflozin used to treat diabetes can also treat heart failure, in patients with and without diabetes (the DAPA-HF Study) – Diabetologia (free)
Randomized Trial: No Difference in Major Cardiovascular Outcomes in Patients with Type 2 Diabetes Treated with DPP-4 Inhibitor vs. Sulfonylurea
20 Sep, 2019 | 08:15h | UTCEffect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Sulfonylureas and Cardiovascular Safety: The Final Verdict? – JAMA (free for a limited period)
Commentary: CAROLINA: No Added Heart Risk With Sulfonylureas – MedPage Today (free registration required)
Cohort Study: Metformin Linked to Reduced Risk of Cardiovascular Events Compared to Sulfonylurea Among Patients with Diabetes and Reduced Kidney Function
20 Sep, 2019 | 08:19h | UTCAssociation of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function – JAMA (free for a limited period)
Commentaries: Metformin Superior for Lowering CV Risk in Diabetics Who Progress to CKD – Renal & Urology News (free) AND Metformin Monotherapy Benefits Heart Even in Early CKD – MedPage Today (free registration required)
Related Commentary on Twitter
Monotherapy treatment with #metformin, compared with a #sulfonylurea, was associated with a lower risk of MACE among patients with diabetes and reduced kidney function https://t.co/Z1EZAjOOET
— JAMA (@JAMA_current) September 19, 2019
Consensus Statement: Healthy Beverage Consumption in Early Childhood: Recommendations from Key Health and Nutrition Organizations
19 Sep, 2019 | 10:28h | UTCConsensus Statement: Healthy Beverage Consumption in Early Childhood: Recommendations from Key National Health and Nutrition Organizations – Health Eating Research (free PDF)
News Releases: 4 groups issue consensus report on healthy beverages for 0- to 5-year-olds – American Academy of Pediatrics (free) AND Leading Health Organizations Support First-Ever Consensus Recommendations to Encourage Young Children’s Consumption of Healthy Drinks – American Heart Association (free)
Commentaries: What Should Young Children Drink? Mostly Milk and Water, Scientists Say – The New York Times (10 articles per month are free) AND Parents Should Limit Kids’ Juice Consumption, Guidelines Say – U.S. News (free)
See also: Health Kids, Health Drinks (free resources for the public)
Related: AAP/AHA Policy Statement: Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents (free)
[Abstract Only] Randomized Trial: GLP-1 Receptor Agonist Superior to SGLT2 Inhibitor for Glucose Control and Weight Loss in Patients with Type 2 Diabetes Uncontrolled on Metformin Therapy
19 Sep, 2019 | 07:51h | UTCEfficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial – The Lancet Endocrinology & Metabolism (link to abstract – $ for full-text)
Commentary: Add-On Diabetes Treatment: Semaglutide Improves HbA1c Better Than Canagliflozin – NEJM Journal Watch (free)
[Abstract Only] Randomized Trial: Early Combination Therapy Provides Greater and Durable Long-term Glucose Control in Patients with Newly Diagnosed Type 2 Diabetes
19 Sep, 2019 | 07:49h | UTCGlycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial – The Lancet (link to abstract – $ for full-text)
Commentaries: Two-drug combo more effective at lowering blood sugar in diabetes patients – UPI (free) AND New study shows long-term durability of early combination therapy in patients newly diagnosed with type 2 diabetes – MedicalXpress (free)
[Abstract Only] Study: Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Disease
18 Sep, 2019 | 08:36h | UTCPersonalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit–Harm Analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Aspirin may benefit some people without cardiovascular disease, new analysis finds – ACP Internist (free) AND Some Adults Without Heart Disease May Benefit From Aspirin – MedicalResearch.com (free) AND Expert reaction to study looking at benefits and harms of aspirin in people without cardiovascular disease – Science Media Centre (free)
[Abstract Only] Meta-Analysis: Cardiovascular, Mortality, and Kidney Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
18 Sep, 2019 | 01:34h | UTCCardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: GLP-1 RA Benefits Extend Beyond MACE Reduction – MedPage Today (free registration required)
Source: EvidenceAlerts